Literature DB >> 20043284

Matrix metalloproteinase-9 reversibly affects the time course of NMDA-induced currents in cultured rat hippocampal neurons.

Tomasz Gorkiewicz1, Katarzyna Szczuraszek, Paulina Wyrembek, Piotr Michaluk, Leszek Kaczmarek, Jerzy W Mozrzymas.   

Abstract

Matrix Metalloproteinase 9 (MMP-9) has been demonstrated to play a crucial role in maintenance of NMDA receptor-dependent LTP and in lateral mobility of these receptors. However, the effect of MMP-9 on NMDA receptor (NMDAR) functional properties is unknown. For this purpose we have investigated the impact of recombinant MMP-9 on the whole-cell NMDAR-mediated current responses in cultured hippocampal neurons. Treatment with MMP-9 induced a reversible acceleration of desensitization and deactivation kinetics but had no effect on current amplitude. Interestingly, phorbol ester, a PKC activator known to enhance NMDAR lateral mobility, induced kinetic changes of currents similar to those produced by MMP-9. In conclusion, our results show that MMP-9 reversibly modulates the NMDAR kinetics and raise a possibility that this modulation could be related to the lateral mobility of these receptors.
© 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20043284     DOI: 10.1002/hipo.20736

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  12 in total

1.  Astrocyte mediated MMP-9 activation in the synapse dysfunction: An implication in Alzheimer disease.

Authors:  Pradip K Kamat; Supriya Swarnkar; Shivika Rai; Vijay Kumar; Neetu Tyagi
Journal:  Ther Targets Neurol Dis       Date:  2014

Review 2.  ERK in learning and memory: a review of recent research.

Authors:  Sheng Peng; Yan Zhang; Jiannan Zhang; Hua Wang; Bingxu Ren
Journal:  Int J Mol Sci       Date:  2010-01-13       Impact factor: 6.208

3.  Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy.

Authors:  Krista J Spiller; Claudia J Cheung; Clark R Restrepo; Linda K Kwong; Anna M Stieber; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2016-07-20       Impact factor: 6.167

Review 4.  Synaptic circuit remodelling by matrix metalloproteinases in health and disease.

Authors:  George W Huntley
Journal:  Nat Rev Neurosci       Date:  2012-10-10       Impact factor: 34.870

5.  Minocycline attenuates mechanical allodynia and expression of spinal NMDA receptor 1 subunit in rat neuropathic pain model.

Authors:  Shaofeng Pu; Yongming Xu; Dongping Du; Meirong Yang; Xin Zhang; Junzhen Wu; Wei Jiang
Journal:  J Physiol Biochem       Date:  2012-11-01       Impact factor: 4.158

6.  Matrix metalloproteinase 9 (MMP-9) is indispensable for long term potentiation in the central and basal but not in the lateral nucleus of the amygdala.

Authors:  Tomasz Gorkiewicz; Marcin Balcerzyk; Leszek Kaczmarek; Ewelina Knapska
Journal:  Front Cell Neurosci       Date:  2015-03-11       Impact factor: 5.505

7.  Matrix Metalloprotease 3 Activity Supports Hippocampal EPSP-to-Spike Plasticity Following Patterned Neuronal Activity via the Regulation of NMDAR Function and Calcium Flux.

Authors:  Patrycja Brzdąk; Jakub Włodarczyk; Jerzy W Mozrzymas; Tomasz Wójtowicz
Journal:  Mol Neurobiol       Date:  2016-06-28       Impact factor: 5.590

Review 8.  Diverse impact of acute and long-term extracellular proteolytic activity on plasticity of neuronal excitability.

Authors:  Tomasz Wójtowicz; Patrycja Brzdąk; Jerzy W Mozrzymas
Journal:  Front Cell Neurosci       Date:  2015-08-10       Impact factor: 5.505

9.  Long-term depression-inducing stimuli promote cleavage of the synaptic adhesion molecule NGL-3 through NMDA receptors, matrix metalloproteinases and presenilin/γ-secretase.

Authors:  Hyejin Lee; Eun-Jae Lee; Yoo Sung Song; Eunjoon Kim
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-12-02       Impact factor: 6.237

Review 10.  Matrix metalloproteinase-9 involvement in the structural plasticity of dendritic spines.

Authors:  Michal Stawarski; Marzena Stefaniuk; Jakub Wlodarczyk
Journal:  Front Neuroanat       Date:  2014-07-10       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.